Literature DB >> 24467982

Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?

Sana M Al-Khatib1, Joo Y Han2, Rex Edwards3, Gust H Bardy2, J Thomas Bigger4, Alfred E Buxton5, Riccardo Cappato6, Paul Dorian7, Al Hallstrom2, Alan H Kadish8, Peter J Kudenchuk2, Kerry L Lee3, Daniel B Mark3, Arthur J Moss9, Richard Steinman4, Lurdes Y T Inoue2, Gillian D Sanders3.   

Abstract

Entities:  

Keywords:  Ejection fraction; Implantable cardioverter defibrillator; Survival

Mesh：

Year:  2014        PMID： 24467982     DOI： 10.1016/j.ijcard.2013.12.278

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Atrial fibrillation: Challenging the status quo: β-blockers for HF plus AF.

Authors:  Paul Khairy; Denis Roy
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

2.  Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

Authors:  Sana M Al-Khatib; Anne S Hellkamp; Gregg C Fonarow; Daniel B Mark; Lesley H Curtis; Adrian F Hernandez; Kevin J Anstrom; Eric D Peterson; Gillian D Sanders; Hussein R Al-Khalidi; Bradley G Hammill; Paul A Heidenreich; Stephen C Hammill
Journal:  JAMA       Date:  2014-06-04       Impact factor: 56.272

Review 3.  Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.

Authors:  Brian P Halliday; John G F Cleland; Jeffrey J Goldberger; Sanjay K Prasad
Journal:  Circulation       Date:  2017-07-11       Impact factor: 29.690
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.